Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL126546 | 0.82 | TSHR (0.48) | TSHR | |
| SCHEMBL1818664 | 0.81 | LMNA (0.38) | LMNA | |
| SCHEMBL15771640 | 0.79 | DNM1 (0.35) | DNM1OPRM1ACE2TSHRALDH1A1 | |
| SCHEMBL15771297 | 0.79 | DNM1 (0.35) | DNM1OPRM1ACE2TSHRALDH1A1 | |
| SCHEMBL56652 | 0.78 | LMNA (0.50) | DNM1OPRM1ACE2TSHRALDH1A1 | |
| SCHEMBL1818542 | 0.78 | TSHR (0.43) | ACE2TSHR | |
| SCHEMBL11043889 | 0.77 | TSHR (0.34) | DNM1OPRM1ACE2TSHRLMNA | |
| SCHEMBL335389 | 0.76 | DNM1 (0.36) | DNM1OPRM1TSHRALDH1A1LMNA | |
| SCHEMBL31521551 | 0.76 | LMNA (0.56) | DNM1OPRM1ACE2TSHRALDH1A1 | |
| SCHEMBL27558484 | 0.76 | ACE2 (0.52) | DNM1OPRM1ACE2TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 341 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0729480-B1 | ADDITION POLYMERS DERIVED FROM NORBORNENE-FUNCTIONAL MONOMERS AND PROCESS THEREFOR | GOODRICH CO B F (US) | 1999-01-27 | — | — | EP | claimed |
| US-5741869-A | REACTION MIXTURE FOR FORMING ADDITION POLYMER COMPRISING NORBORNENE-FUNCTIONAL MONOMER, SOLVENT, GROUP 8 METAL-CONTAINING CATALYST SYSTEM, CHAIN TRANSFER AGENT | THE B.F. GOODRICH COMPANY (US) | 1998-04-21 | — | — | US | claimed |
| US-5714426-A | COORDINATION CATALYST COMPRISING AN ETHYLENEBIS(INDENYL)HAFNIUM AND AN ALUMINUM COMPOUND OR ALUMOXANE; ETHYLENE COPOLYMERS HAVING EXCELLENT FLOWABILITY AND NARROW MOLECULAR WEIGHT DISTRIBUTION; PACKAGING FILMS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1998-02-03 | — | — | US | claimed |
| EP-0758657-A2 | Addition polymers derived from norbornene-functional monomers and process therefor | The B.F. Goodrich Company (US) | 1997-02-19 | — | — | EP | claimed |
| EP-0729480-A1 | ADDITION POLYMERS DERIVED FROM NORBORNENE-FUNCTIONAL MONOMERS AND PROCESS THEREFOR | The B.F. Goodrich Company (US) | 1996-09-04 | — | — | EP | claimed |
| WO-1995014048-A9 | ADDITION POLYMERS DERIVED FROM NORBORNENE-FUNCTIONAL MONOMERS AND PROCESS THEREFOR | — | 1995-07-27 | — | — | WO | claimed |
| WO-1995014048-A1 | ADDITION POLYMERS DERIVED FROM NORBORNENE-FUNCTIONAL MONOMERS AND PROCESS THEREFOR | THE B.F. GOODRICH COMPANY (US) | 1995-05-26 | — | — | WO | claimed |
| WO-2024079203-A1 | CATALYST SYSTEM BASED ON AN IRON COMPLEX AND USE THEREOF FOR THE POLYMERIZATION OF CONJUGATED DIENES | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2024-04-18 | — | — | WO | disclosed |
| US-11691136-B2 | Olefin oligomerization catalyst and method for producing olefin oligomer in the presence of the same catalyst | MITSUI CHEMICALS, INC. (JP) | 2023-07-04 | — | — | US | disclosed |
| WO-2023101004-A1 | OLEFIN RESIN, METHOD FOR MANUFACTURING SAME, AND APPLICATION FOR SAME | 三井化学株式会社 | 2023-06-08 | — | — | WO | disclosed |
| EP-3124506-B1 | OLEFIN RESIN AND METHOD FOR PRODUCING SAME | MITSUI CHEMICALS INC (JP) | 2022-06-22 | — | — | EP | disclosed |
| US-10870715-B2 | Solid polyaluminoxane composition, olefin polymerization catalyst, olefin polymer production method and solid polyaluminoxane composition production method | MITSUI CHEMICALS, INC. (JP) | 2020-12-22 | — | — | US | disclosed |
| US-20200222886-A1 | OLEFIN OLIGOMERIZATION CATALYST AND METHOD FOR PRODUCING OLEFIN OLIGOMER IN THE PRESENCE OF THE SAME CATALYST | MITSUI CHEMICALS, INC. (JP) | 2020-07-16 | — | — | US | disclosed |
| US-5023222-A | Coordination catalyst containing titanium compound and methyl group containing organoaluminum compound | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1991-06-11 | — | — | US | disclosed |
| US-4978730-A | COORDINATION CATALYSTS FOR POLYMERIZATION OF SYNDIOTACTIC POLYSTYRENES | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1990-12-18 | — | — | US | disclosed |
| EP-0363029-A2 | Olefin polymerization catalyst component, olefin polymerization catalyst and process for the polymerization of olefins | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1990-04-11 | — | — | EP | disclosed |
| EP-0328348-A2 | Olefin polymerization catalyst and process for the polymerization of olefins | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-08-16 | — | — | EP | disclosed |
| EP-0324856-A1 | PROCESS FOR POLYMERIZING OLEFIN | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-26 | — | — | EP | disclosed |
| EP-0322663-A2 | Process for producing styrene-based polymers and catalyst for use therein | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1989-07-05 | — | — | EP | disclosed |
| EP-0287666-A1 | PROCESS FOR POLYMERIZING OLEFINS | Mitsui Chemicals, Inc. (JP) | 1988-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200222886-A1 | OLEFIN OLIGOMERIZATION CATALYST AND METHOD FOR PRODUCING OLEFIN OLIGOMER IN THE PRESENCE OF THE SAME CATALYST | OXER1, COG6, CBR1 | DNM1 1608/4885OPRM1 67/4885ACE2 4542/4885 |
| US-11691136-B2 | Olefin oligomerization catalyst and method for producing olefin oligomer in the presence of the same catalyst | OXER1, COG6, CBR1 | DNM1 1608/4885OPRM1 67/4885ACE2 4542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.